Pather S - Search Results

1

Clinical development and approval of COVID-19 vaccines.

Kalinke U, Barouch DH, Rizzi R, Lagkadinou E, Türeci Ö, Pather S, Neels P. Kalinke U, et al. Among authors: pather s. Expert Rev Vaccines. 2022 May;21(5):609-619. doi: 10.1080/14760584.2022.2042257. Epub 2022 Mar 14. Expert Rev Vaccines. 2022. PMID: 35157542 Free PMC article.

2

Yang J, Rai KK, Seif M, Volkman HR, Ren J, Schmetz A, Gowman H, Massey L, Pather S, Nguyen JL. Yang J, et al. Among authors: pather s. J Occup Environ Med. 2024 Jun 1;66(6):514-522. doi: 10.1097/JOM.0000000000003093. Epub 2024 Mar 14. J Occup Environ Med. 2024. PMID: 38489399

3

The Impact of Evolving SARS-CoV-2 Mutations and Variants on COVID-19 Vaccines.

McLean G, Kamil J, Lee B, Moore P, Schulz TF, Muik A, Sahin U, Türeci Ö, Pather S. McLean G, et al. Among authors: pather s. mBio. 2022 Apr 26;13(2):e0297921. doi: 10.1128/mbio.02979-21. Epub 2022 Mar 30. mBio. 2022. PMID: 35352979 Free PMC article. Review.

4

Addressing COVID-19 vaccine hesitancy.

Kassianos G, Puig-Barberà J, Dinse H, Teufel M, Türeci Ö, Pather S. Kassianos G, et al. Among authors: pather s. Drugs Context. 2022 Jun 20;11:2021-12-3. doi: 10.7573/dic.2021-12-3. eCollection 2022. Drugs Context. 2022. PMID: 35814493 Free PMC article. Review.

5

COVID-19 Epidemiology, Immunity, and Vaccine Development in Children: A Review.

Fergie J, Moran MM, Cane A, Pather S, Türeci Ӧ, Srivastava A. Fergie J, et al. Among authors: pather s. Vaccines (Basel). 2022 Nov 29;10(12):2039. doi: 10.3390/vaccines10122039. Vaccines (Basel). 2022. PMID: 36560448 Free PMC article. Review.

6

SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines.

Pather S, Madhi SA, Cowling BJ, Moss P, Kamil JP, Ciesek S, Muik A, Türeci Ö. Pather S, et al. Front Immunol. 2023 May 23;14:1130539. doi: 10.3389/fimmu.2023.1130539. eCollection 2023. Front Immunol. 2023. PMID: 37287979 Free PMC article. Review.

7

Corrigendum: SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines.

Pather S, Madhi SA, Cowling BJ, Moss P, Kamil JP, Ciesek S, Muik A, Türeci Ö. Pather S, et al. Front Immunol. 2023 Jun 12;14:1232965. doi: 10.3389/fimmu.2023.1232965. eCollection 2023. Front Immunol. 2023. PMID: 37377964 Free PMC article.

8

Clinical development of variant-adapted BNT162b2 COVID-19 vaccines: the early Omicron era.

Pather S, Muik A, Rizzi R, Mensa F. Pather S, et al. Expert Rev Vaccines. 2023 Jan-Dec;22(1):650-661. doi: 10.1080/14760584.2023.2232851. Expert Rev Vaccines. 2023. PMID: 37417000 Free article. Review.

9

Responses to Common Misconceptions Relating to COVID-19 Variant-Adapted mRNA Vaccines.

Kassianos G, MacDonald P, Aloysius I, Pather S. Kassianos G, et al. Among authors: pather s. Vaccines (Basel). 2024 Jan 6;12(1):57. doi: 10.3390/vaccines12010057. Vaccines (Basel). 2024. PMID: 38250870 Free PMC article. Review.

10

Safety and reactogenicity of the BNT162b2 COVID-19 vaccine: Development, post-marketing surveillance, and real-world data.

van den Ouweland F, Charpentier N, Türeci Ö, Rizzi R, Mensa FJ, Lindemann C, Pather S. van den Ouweland F, et al. Among authors: pather s. Hum Vaccin Immunother. 2024 Dec 31;20(1):2315659. doi: 10.1080/21645515.2024.2315659. Epub 2024 Feb 26. Hum Vaccin Immunother. 2024. PMID: 38407186 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

153 results

Search Page

Filters